Detection of oxidized high-density lipoprotein (Q35008823)

5 August 2017

1 reference

title

Detection of oxidized high-density lipoprotein (English)

1 reference

5 August 2017

1 reference

1

Toshiyuki Matsunaga

1 reference

5 August 2017

Iwao Koyama

2

1 reference

5 August 2017

Shigeru Hokari

series ordinal

3

1 reference

5 August 2017

Tsugikazu Komoda

series ordinal

4

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

5 August 2017

published in

1 reference

5 August 2017

volume

781

1 reference

5 August 2017

issue

1-2

1 reference

5 August 2017

page(s)

331-343

1 reference

The role of oxidized lipoproteins in atherogenesis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Sensitivity of tryptophan and related compounds to oxidation induced by lipid autoperoxidation. Application to human serum low- and high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Oxidized HDL are much less cytotoxic to lymphoblastoid cells than oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Modified apolipoprotein pattern after irradiation of human high-density lipoproteins by ultraviolet B

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Characterization of a specific monoclonal antibody 9F5-3a and the development of assay system for oxidized HDL

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Microviscosity of lipid domains in human serum lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Physicochemical changes in human high-density lipoproteins (HDL) oxidized by gamma radiolysis-generated oxyradicals. Effect on their cholesterol effluxing capacity

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Membrane damage due to lipid oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Biophysical consequences of lipid peroxidation in membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Possible role of high susceptibility of high-density lipoprotein to lipid peroxidative modification and oxidized high-density lipoprotein in genesis of coronary artery spasm

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

In vitro oxidised HDL exerts a cytotoxic effect on macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Lipid peroxides and human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Cross-linking of apolipoproteins is involved in a loss of the ligand activity of high density lipoprotein upon Cu(2+)-mediated oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Chemical cross-linking alters high-density lipoprotein to be recognized by a scavenger receptor in rat peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

A mechanistic study of the interaction of UVB radiations with human serum lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Apolipoprotein-lipid association in oxidatively modified HDL and LDL

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Sequential flotation ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Anion-exchange high-performance liquid chromatography assays of plasma lipoproteins and modified low-density lipoproteins using a ProtEx-DEAE column.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Electrophoresis of pig serum lipoproteins in agarose gel

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Interaction of oxidized HDLs with J774-A1 macrophages causes intracellular accumulation of unesterified cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Lipid extraction of tissues with a low-toxicity solvent

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

A high-performance liquid chromatographic procedure for the determination of disaturated phosphatidylcholine in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Uptake of endogenous cholesterol by a synthetic lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Separation and quantification of cholesterol and major phospholipid classes in human semen by high-performance liquid chromatography and light-scattering detection

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Analysis of phospholipid species in human blood using normal-phase liquid chromatography coupled with electrospray ionization ion-trap tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Estimation of lipid peroxidation of live cells using a fluorescent probe, diphenyl-1-pyrenylphosphine

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Development of phosphine reagents for the high-performance liquid chromatographic-fluorometric determination of lipid hydroperoxides.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Chromatographic methods for quantitation of apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

The rediscovery of high density lipoprotein: a negative risk factor in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Cholesterol transport between cells and high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Reduced cholesterol efflux to mildly oxidized high density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Comparison of serum lipid values in variant angina pectoris and fixed coronary artery disease with normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Low serum apolipoprotein A-I level in patients with vasospastic angina

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Low density lipoprotein undergoes oxidative modification in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Purification and characterization of two high-density-lipoprotein-binding proteins from rat and human liver

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

In vitro oxidised HDL is recognized by the scavenger receptor of macrophages: implications for its protective role in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Inactivation of endothelial derived relaxing factor by oxidized lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

The protective role of high-density lipoprotein on oxidized-low-density-lipoprotein-induced U937/endothelial cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Oxidized lipoproteins including HDL and their lipid peroxidation products inhibit TNF-alpha secretion by THP-1 human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Protective effect of lipoproteins containing apoprotein A-I on Cu2+-catalyzed oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

How high-density lipoprotein protects against the effects of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

HDL, its enzymes and its potential to influence lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin cholesterol acyltransferase activation

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Effect of apoprotein cross-linking on the metabolism of human HDL3 in rat

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

In vivo kinetics of oxidatively modified HDL

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Modification of lipoproteins in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Lipoprotein glycation and its metabolic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Lipid peroxide levels of serum lipoprotein fractions of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Glycation impairs high-density lipoprotein function

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Role of the vascular NADH/NADPH oxidase system in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900556-1

7 January 2021

10.1016/S1570-0232(02)00556-1

Identifiers

DOI

1 reference

5 August 2017

1 reference